NAGE Chromadex Corp Sotuvning sof marjinal rentabelligi

Ommaviy kompaniya ChromaDex Corp. (NAGE) logotipi

Chromadex Corp NAD+ tadqiqotlariga rahbarlik qilmoqda va Niagen mahsulotini patentlar bilan himoya qilmoqda, shu sababli GURU.Markets platformasidagi operatsion sof marja joriy 8.40 ko'rsatkichini beradi. Rojalti orqali hujayralarni yoshartirish huquqlarining monetizatsiyasi barqarorlikni ta'minlaydi. Parhez qo'shimchalari shartnomalarining o'sishi va yangi testlar rivojlanish uchun asos yaratmoqda, shu bilan birga bozor mahsulotlarni joriy etish samaradorligini baholamoqda.

niagenbioscience.com (NAGE) Sotuvning sof rentabelligi: 20.03.2025 - 19.11.2026 davri uchun

ChromaDex Corp (NAGE) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning asosiy tahlili:Chromadex Corp - NAGE
ChromaDex Corp. ishlab chiqargan mahsulot

Niagen uchun eksklyuziv patentlar va biohacking segmentidagi talabning past elastikligi tufayli Chromadex Corp (NAGE) inflyatsiyaviy xarajatlarni iste'molchilarga samarali ravishda o'tkazmoqda. Sof marjani tushumning foizi sifatida tahlil qilish orqali investor har bir sotuv dollaridagi yakuniy foyda ulushini baholaydi, bu esa biznesning ko'tarilayotgan stavkalarga moslashish tezligini belgilaydi va emitent kapitalining barqarorligini tasdiqlaydi.

Chromadex Corp kimlar bilan raqobatlashadi

Intuitive Surgical, Inc. (ISRG) - Sof marja|Sof marja Danaher Corporation (DHR)|Sof marja Becton Dickinson & Co|Sotuvning sof rentabelligi STE (STERIS plc)|Sof foyda bo'yicha sotuv rentabelligi WST (West Pharmaceutical Services Inc)|Kompaniyaning sof rentabelligi BAX|Masimo Corporation - Sof foyda bo'yicha sotuv rentabelligi|Kompaniyaning sof rentabelligi STVN (Stevanato Group SpA)|TFX: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi Merit Medical Corp MMSI|NVST: Sotuvning sof marjinal rentabelligi|ICUI - Kompaniya sotuv marjasi|XRAY (Sirona Dental Systems) - Sotuvning sof marjinal rentabelligi|Sof marja LeMaitre Vascular Inc LMAT|Sof marja AtriCure Corp (ATRC)|Sotuvning sof marjinal rentabelligi STAAR Surgical Corp (STAA)|ZimVie Inc. - Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi angiodynamics.com (ANGO)|CERS - Sof marja|TKNO - Sotuvning sof marjinal rentabelligi|Monogram Technologies Inc (MGRM) - Sof marja|STSS - Kompaniya sotuv marjasi|Sof marja InfuSystem Holdings, Inc.|Sof marja Utah Medical Products UTMD|Sotuvning sof marjinal rentabelligi KRMD|Kompaniya sotuv marjasi Nyxoah, S.A.|Microbot Medical Inc - Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi Pro-Dex Inc. (PDEX)|Zentek - Sotuvning sof marjinal rentabelligi|Elutia (ELUT) - Sof foyda bo'yicha sotuv rentabelligi|Milestone Scientific Inc (MLSS) - Sof marja|NXGL - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RVP|Harvard Bioscience, Inc. (HBIO) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi FEMY|Sotuvning sof marjinal rentabelligi Meihua Medical Technologies (MHUA)|Sotuvning sof marjinal rentabelligi POAI (Predictive Oncology)|CJMB - Sof foyda bo'yicha sotuv rentabelligi|ATRI: Sof foyda bo'yicha sotuv rentabelligi|NeuroMetrix, Inc. (NURO) - Sof foyda bo'yicha sotuv rentabelligi